Mealey's (October 4, 2022, 3:34 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on Oct. 3 denied a request by drug manufacturer Bayer Healthcare Pharmaceuticals Inc. to require the Ninth Circuit U.S. Court of Appeals to apply a more expansive standard in deciding if a distributor was fraudulently joined in three gadolinium injury cases....